Annual CAPEX
$139.43 M
+$26.97 M+23.98%
31 December 2022
Summary:
NuVasive annual capital expenditures is currently $139.43 million, with the most recent change of +$26.97 million (+23.98%) on 31 December 2022. During the last 3 years, it has risen by +$29.84 million (+27.23%).NUVA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$37.01 M
+$1.86 M+5.30%
30 June 2023
Summary:
NuVasive quarterly capital expenditures is currently $37.01 million, with the most recent change of +$1.86 million (+5.30%) on 30 June 2023.NUVA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$142.84 M
+$1.49 M+1.05%
30 June 2023
Summary:
NuVasive TTM capital expenditures is currently $142.84 million, with the most recent change of +$1.49 million (+1.05%) on 30 June 2023.NUVA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NUVA CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | +27.2% | +15.1% | +24.5% |
5 y5 years | +27.2% | +24.5% | +13.9% |
NUVA CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time | at high | -36.3% | at high |
NuVasive CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2023 | - | $37.01 M(+5.3%) | $142.84 M(+1.1%) |
Mar 2023 | - | $35.15 M(+8.8%) | $141.35 M(+1.4%) |
Dec 2022 | $139.43 M(+24.0%) | $32.31 M(-15.8%) | $139.43 M(+5.0%) |
Sept 2022 | - | $38.38 M(+8.0%) | $132.75 M(+4.9%) |
June 2022 | - | $35.52 M(+6.9%) | $126.52 M(+6.0%) |
Mar 2022 | - | $33.22 M(+29.6%) | $119.41 M(+6.2%) |
Dec 2021 | $112.46 M(+2.6%) | $25.63 M(-20.3%) | $112.46 M(-2.0%) |
Sept 2021 | - | $32.15 M(+13.1%) | $114.75 M(+4.6%) |
June 2021 | - | $28.41 M(+8.2%) | $109.72 M(+4.2%) |
Mar 2021 | - | $26.27 M(-5.9%) | $105.25 M(-4.0%) |
Dec 2020 | $109.59 M(-15.9%) | $27.92 M(+3.0%) | $109.59 M(-0.5%) |
Sept 2020 | - | $27.11 M(+13.2%) | $110.12 M(-2.3%) |
June 2020 | - | $23.95 M(-21.8%) | $112.73 M(-6.2%) |
Mar 2020 | - | $30.61 M(+7.6%) | $120.23 M(-7.8%) |
Dec 2019 | $130.38 M(+19.0%) | $28.45 M(-4.3%) | $130.38 M(+3.9%) |
Sept 2019 | - | $29.72 M(-5.5%) | $125.45 M(+3.9%) |
June 2019 | - | $31.46 M(-22.8%) | $120.75 M(+1.8%) |
Mar 2019 | - | $40.76 M(+73.3%) | $118.59 M(+8.2%) |
Dec 2018 | $109.60 M(-2.6%) | $23.52 M(-6.0%) | $109.60 M(+10.4%) |
Sept 2018 | - | $25.02 M(-14.6%) | $99.28 M(-3.8%) |
June 2018 | - | $29.30 M(-7.8%) | $103.18 M(-4.9%) |
Mar 2018 | - | $31.77 M(+140.8%) | $108.46 M(-3.6%) |
Dec 2017 | $112.49 M(+19.3%) | $13.19 M(-54.4%) | $112.49 M(-1.1%) |
Sept 2017 | - | $28.91 M(-16.4%) | $113.79 M(+7.2%) |
June 2017 | - | $34.59 M(-3.4%) | $106.19 M(-4.1%) |
Mar 2017 | - | $35.79 M(+147.0%) | $110.78 M(+17.5%) |
Dec 2016 | $94.29 M(-12.5%) | $14.49 M(-32.0%) | $94.29 M(-4.9%) |
Sept 2016 | - | $21.32 M(-45.6%) | $99.10 M(+10.5%) |
June 2016 | - | $39.18 M(+102.9%) | $89.71 M(+30.0%) |
Mar 2016 | - | $19.31 M(+0.0%) | $69.02 M(-36.0%) |
Dec 2015 | $107.79 M(+84.5%) | $19.30 M(+61.8%) | $107.79 M(+6.5%) |
Sept 2015 | - | $11.93 M(-35.5%) | $101.23 M(-1.2%) |
June 2015 | - | $18.48 M(-68.2%) | $102.43 M(-0.7%) |
Mar 2015 | - | $58.08 M(+356.2%) | $103.12 M(+76.5%) |
Dec 2014 | $58.42 M(-1.7%) | $12.73 M(-3.0%) | $58.42 M(-12.9%) |
Sept 2014 | - | $13.13 M(-31.5%) | $67.10 M(+2.0%) |
June 2014 | - | $19.17 M(+43.2%) | $65.78 M(+3.4%) |
Mar 2014 | - | $13.39 M(-37.5%) | $63.62 M(+7.1%) |
Dec 2013 | $59.43 M | $21.41 M(+81.3%) | $59.43 M(+36.6%) |
Sept 2013 | - | $11.81 M(-30.6%) | $43.50 M(+0.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2013 | - | $17.01 M(+84.9%) | $43.47 M(+21.3%) |
Mar 2013 | - | $9.20 M(+67.8%) | $35.82 M(-13.0%) |
Dec 2012 | $41.19 M(-29.4%) | $5.48 M(-53.4%) | $41.19 M(-17.0%) |
Sept 2012 | - | $11.78 M(+25.8%) | $49.64 M(+0.6%) |
June 2012 | - | $9.36 M(-35.7%) | $49.36 M(-10.2%) |
Mar 2012 | - | $14.57 M(+4.5%) | $54.94 M(-5.9%) |
Dec 2011 | $58.37 M(+27.3%) | $13.94 M(+21.3%) | $58.37 M(+8.8%) |
Sept 2011 | - | $11.49 M(-23.1%) | $53.66 M(-5.4%) |
June 2011 | - | $14.94 M(-17.0%) | $56.73 M(+2.3%) |
Mar 2011 | - | $18.00 M(+95.1%) | $55.44 M(+20.9%) |
Dec 2010 | $45.85 M(+39.4%) | $9.22 M(-36.7%) | $45.85 M(-5.0%) |
Sept 2010 | - | $14.56 M(+6.6%) | $48.25 M(+13.5%) |
June 2010 | - | $13.66 M(+62.5%) | $42.50 M(+19.0%) |
Mar 2010 | - | $8.40 M(-27.7%) | $35.71 M(+8.6%) |
Dec 2009 | $32.88 M(-17.4%) | $11.63 M(+32.0%) | $32.88 M(+22.3%) |
Sept 2009 | - | $8.81 M(+28.2%) | $26.88 M(+32.5%) |
June 2009 | - | $6.87 M(+23.5%) | $20.29 M(-40.3%) |
Mar 2009 | - | $5.57 M(-1.2%) | $33.99 M(-14.6%) |
Dec 2008 | $39.80 M(+63.1%) | $5.63 M(+153.9%) | $39.80 M(-10.5%) |
Sept 2008 | - | $2.22 M(-89.2%) | $44.46 M(-7.0%) |
June 2008 | - | $20.57 M(+81.0%) | $47.82 M(+40.3%) |
Mar 2008 | - | $11.37 M(+10.4%) | $34.07 M(+39.6%) |
Dec 2007 | $24.40 M(+19.6%) | $10.30 M(+84.7%) | $24.40 M(+37.1%) |
Sept 2007 | - | $5.58 M(-18.3%) | $17.79 M(-12.6%) |
June 2007 | - | $6.83 M(+302.2%) | $20.36 M(+1.0%) |
Mar 2007 | - | $1.70 M(-54.0%) | $20.16 M(-1.2%) |
Dec 2006 | $20.40 M(+60.9%) | $3.69 M(-54.7%) | $20.40 M(+1.7%) |
Sept 2006 | - | $8.14 M(+22.9%) | $20.06 M(+40.2%) |
June 2006 | - | $6.63 M(+242.7%) | $14.30 M(+38.1%) |
Mar 2006 | - | $1.93 M(-42.3%) | $10.36 M(-18.3%) |
Dec 2005 | $12.68 M(+106.5%) | $3.35 M(+40.2%) | $12.68 M(-7.4%) |
Sept 2005 | - | $2.39 M(-10.8%) | $13.68 M(+17.8%) |
June 2005 | - | $2.68 M(-37.0%) | $11.62 M(+18.1%) |
Mar 2005 | - | $4.25 M(-2.5%) | $9.84 M(+60.2%) |
Dec 2004 | $6.14 M(+116.1%) | $4.36 M(+1233.3%) | $6.14 M(+245.1%) |
Sept 2004 | - | $327.00 K(-63.6%) | $1.78 M(+22.5%) |
June 2004 | - | $898.00 K(+62.1%) | $1.45 M(+162.1%) |
Mar 2004 | - | $554.00 K | $554.00 K |
Dec 2003 | $2.84 M(+125.7%) | - | - |
Dec 2002 | $1.26 M | - | - |
FAQ
- What is NuVasive annual capital expenditures?
- What is the all time high annual CAPEX for NuVasive?
- What is NuVasive quarterly capital expenditures?
- What is the all time high quarterly CAPEX for NuVasive?
- What is NuVasive TTM capital expenditures?
- What is the all time high TTM CAPEX for NuVasive?
What is NuVasive annual capital expenditures?
The current annual CAPEX of NUVA is $139.43 M
What is the all time high annual CAPEX for NuVasive?
NuVasive all-time high annual capital expenditures is $139.43 M
What is NuVasive quarterly capital expenditures?
The current quarterly CAPEX of NUVA is $37.01 M
What is the all time high quarterly CAPEX for NuVasive?
NuVasive all-time high quarterly capital expenditures is $58.08 M
What is NuVasive TTM capital expenditures?
The current TTM CAPEX of NUVA is $142.84 M
What is the all time high TTM CAPEX for NuVasive?
NuVasive all-time high TTM capital expenditures is $142.84 M